Melbourne, Australia (PRWEB) May 22, 2013
About one in six Australian couples suffer infertility, which has made the Fertility Clinics industry one of the fastest growing industries in the health sector. The industry assists patients who are unable to conceive naturally through a variety of treatment options, the most common and popular of which is in-vitro fertilisation (IVF) cycles. Over the past five years, the number of completed IVF cycles in Australia has increased by 4.4% per annum to a forecast 40,000 cycles in 2012-13. According to IBISWorld industry analyst Naren Sivasailam, “a number of factors have led to the strong growth in demand for infertility treatments and procedures, particularly growth in women who are choosing to have children later in life”. Further, growth in the infertility rate has contributed to increased incidences of infertile women seeking treatment. Australia is also one of the few developed countries in the world that has substantial government funding for fertility treatments, thereby making seeking treatment economically feasible. In the five years through 2012-13, industry revenue is estimated to increase at a compound annual rate of 11.1%.
The industry is dominated by three major players: Virtus Health Limited, Healthbridge Enterprises Pty Ltd and Genea Limited. “There has been a trend towards increasing market concentration due to the amount of consolidation occurring as a result of mergers and acquisitions”, says Sivasailam. However, establishment numbers are increasing as companies continue expanding. The industry is in a growth life cycle phase because it is relatively young. Participation in industry services is increasing as people become more aware of the benefits of IVF.
The future of the Fertility Clinics industry is expected to be promising. This will be driven by growth in the industry's key target markets and greater awareness of the success of treatment programs. There have been substantial advances in the medical science around infertility treatments, especially in the success rate of IVF cycles when detected at the right age. The prevailing trend of women choosing to have children later in life is also expected to continue over the next five years. The industry will benefit from the changing structure of the Australian population and social trends such as workforce participation. While the industry's major players are expected to remain dominant in providing the full suite of services, smaller players targeting niche segments will grow.
For more information, visit IBISWorld’s Fertility Clinics report in Australia industry page.
Follow IBISWorld on Twitter: http://twitter.com/#!/ibisworldau
IBISWorld Industry Report Key Topics
Medical facilities in this industry offer treatments to aid individuals in conceiving children. These facilities offer diagnosis, medications, intrauterine insemination and other assisted reproductive technology methods.
Key External Drivers
Industry Life Cycle
Products & Markets
Products & Services
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Technology & Systems
Regulation & Policy
About IBISWorld Inc.
Recognised as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every Australian industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Melbourne, IBISWorld serves a range of business, professional service and government organisations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com.au or call (03) 9655 3886.